-
Ixabepilone
- indication:Investigated for use/treatment in breast cancer, head and neck cancer, melanoma, lung cancer, lymphoma (non-hodgkin's), prostate cancer, renal cell carcinoma, and cancer/tumors (unspecified).
- pharmacologypharmacology:
- mechanism: Binding of Ixabepilone to beta-tubulins (e.g. beta-III tubulin) stabilizes microtubules.
- toxicity:
- absorprion:
- halflife:
- roouteelimination:
- volumedistribution:
- clearance: